Codon AG (CHIX:CNWKD) EPS (Basic) : €-0.53 (TTM As of Jun. 2022)

View and export this data going back to 2015. Start your Free Trial

What is Codon AG EPS (Basic)?

Codon AG's basic earnings per share (Basic EPS) for the six months ended in Jun. 2022 was €-0.41. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Jun. 2022 was €-0.53.

Codon AG's EPS (Diluted) for the six months ended in Jun. 2022 was €-0.41. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2022 was €-0.53.

Codon AG's EPS without NRI for the six months ended in Jun. 2022 was €-0.41. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jun. 2022 was -0.53.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Codon AG EPS (Basic) Historical Data

The historical data trend for Codon AG's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Codon AG EPS (Basic) Chart

Codon AG Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

EPS (Basic)

Get a 7-Day Free Trial

-0.65

-0.64

-1.18

-1.29

-0.41

Codon AG Semi-Annual Data
	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22
EPS (Basic)	Get a 7-Day Free Trial															-0.64	-0.65	-0.14	-0.12	-0.41

Codon AG EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Codon AG's Basic EPS for the fiscal year that ended in Dec. 2021 is calculated as

Basic EPS (A: Dec. 2021 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-9.322	-	0)	/	22.830
	=	-0.41

Codon AG's Basic EPS for the quarter that ended in Jun. 2022 is calculated as

Basic EPS (Q: Jun. 2022 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-10.992	-	0)	/	26.810
	=	-0.41

EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2022 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.53

Codon AG (CHIX:CNWKd) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Codon AG EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Codon AG's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Codon AG (CHIX:CNWKD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Codon AG (CHIX:CNWKd) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

Warthestrasse 21, Teltow, DEU, 14513

Website

http://www.codon.de

Codon AG develops, produces and distributes autologous cell therapies for the minimally invasive repair of cartilage defects. The product being marketed is a cell therapy product for the minimally invasive treatment of cartilage damage in the knee joint that uses only the patient's own cartilage cells (autologous chondrocytes). CODON's method is currently used in over 200 clinics in Germany and more than 14,000 patients have already been treated.

Codon AG (CHIX:CNWKD) Headlines

No Headlines